340B provider groups won some concessions on controversial Medicaid managed care drug billing language that the full U.S. House Energy & Commerce Committee is marking up tomorrow, lobbyists say. Efforts to get more changes continue.
The committee announced late last night that tomorrow it will markup a bipartisan bill with language that, in its original form, would have made it impossible nationally for 340B providers to earn revenue from billing state Medicaid managed care contractors above what they pay for 340B-acquired drugs.
340B provider groups won some concessions on controversial Medicaid managed care drug billing language that the full U.S. House Energy & Commerce Committee is marking up tomorrow, lobbyists say. Efforts to get more changes continue. The committee announced late last […]
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
